Evidence map›Paper›PMID 25543152›Full record

ArticleCell2015

SOX17 is a critical specifier of human primordial germ cell fate.

Naoko Irie, Leehee Weinberger, Walfred W C Tang, Toshihiro Kobayashi, Sergey Viukov, Yair S Manor, Sabine Dietmann, Jacob H Hanna, M Azim Surani

Open access · hybridAbstract read
In one paragraph

Article in Cell, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 472 papers.

0numbers the graph read from it
0cells of the map it votes in
472citing papers in PubMed
30.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

472 citing papers in PubMed, 855 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

412 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Naoko IrieWellcome Trust Cancer Research UK Gurdon Institute, Tennis Court Road, University of Cambridge, Cambridge CB2 1QN, UK; Department of Physiology, Development and Neuroscience, Downing Street, University of Cambridge, Cambridge CB2 3EG, UK; Wellcome Trust-Medical Research Council Stem Cell Institute, Tennis Court Road, University of Cambridge, Cambridge CB2 3EG, UK.
Leehee WeinbergerThe Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 76100, Israel.
Walfred W C TangWellcome Trust Cancer Research UK Gurdon Institute, Tennis Court Road, University of Cambridge, Cambridge CB2 1QN, UK; Department of Physiology, Development and Neuroscience, Downing Street, University of Cambridge, Cambridge CB2 3EG, UK; Wellcome Trust-Medical Research Council Stem Cell Institute, Tennis Court Road, University of Cambridge, Cambridge CB2 3EG, UK.
Toshihiro KobayashiWellcome Trust Cancer Research UK Gurdon Institute, Tennis Court Road, University of Cambridge, Cambridge CB2 1QN, UK; Department of Physiology, Development and Neuroscience, Downing Street, University of Cambridge, Cambridge CB2 3EG, UK; Wellcome Trust-Medical Research Council Stem Cell Institute, Tennis Court Road, University of Cambridge, Cambridge CB2 3EG, UK.
Sergey ViukovThe Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 76100, Israel.
Yair S ManorThe Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 76100, Israel.
Sabine DietmannWellcome Trust-Medical Research Council Stem Cell Institute, Tennis Court Road, University of Cambridge, Cambridge CB2 3EG, UK.
Jacob H HannaThe Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 76100, Israel. Electronic address: jacob.hanna@weizmann.ac.il.
M Azim SuraniWellcome Trust Cancer Research UK Gurdon Institute, Tennis Court Road, University of Cambridge, Cambridge CB2 1QN, UK; Department of Physiology, Development and Neuroscience, Downing Street, University of Cambridge, Cambridge CB2 3EG, UK; Wellcome Trust-Medical Research Council Stem Cell Institute, Tennis Court Road, University of Cambridge, Cambridge CB2 3EG, UK. Electronic address: a.surani@gurdon.cam.ac.uk.
Weizmann Institute of Science · ILWellcome Trust · GBMedical Research Council · GBWellcome/Cancer Research UK Gurdon Institute · GBWellcome/MRC Cambridge Stem Cell Institute · GB

Funding

Wellcome Trust 096738
6 · The paper itself

Abstract

Specification of primordial germ cells (PGCs) marks the beginning of the totipotent state. However, without a tractable experimental model, the mechanism of human PGC (hPGC) specification remains unclear. Here, we demonstrate specification of hPGC-like cells (hPGCLCs) from germline competent pluripotent stem cells. The characteristics of hPGCLCs are consistent with the embryonic hPGCs and a germline seminoma that share a CD38 cell-surface marker, which collectively defines likely progression of the early human germline. Remarkably, SOX17 is the key regulator of hPGC-like fate, whereas BLIMP1 represses endodermal and other somatic genes during specification of hPGCLCs. Notable mechanistic differences between mouse and human PGC specification could be attributed to their divergent embryonic development and pluripotent states, which might affect other early cell-fate decisions. We have established a foundation for future studies on resetting of the epigenome in hPGCLCs and hPGCs for totipotency and the transmission of genetic and epigenetic information.

Indexed as

Cell DifferentiationADP-ribosyl Cyclase 1AnimalsCell Line, TumorEmbryoid BodiesEmbryonic Stem CellsEpigenesis, GeneticGerm CellsHumansInduced Pluripotent Stem CellsMicePositive Regulatory Domain I-Binding Factor 1Repressor ProteinsSeminomaSequence Analysis, RNASOXF Transcription FactorsADP-ribosyl Cyclase 1Positive Regulatory Domain I-Binding Factor 1PRDM1 protein, humanRepressor ProteinsSOX17 protein, humanSOXF Transcription Factors

Identifiers

PMID25543152
PMCPMC4310934
OpenAlexW2059145054

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.